cilazapril, anhydrous has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Lin, H; Mi, X; Sha, Z | 1 |
| Kihara, M; Mitsui, MK; Mitsui, Y; Nakasaka, Y; Okuda, K; Schmelzer, JD; Takahashi, M | 1 |
| Patumraj, S; Udayachalerm, W; Vechakarn, O | 1 |
3 other study(ies) available for cilazapril, anhydrous and Alloxan Diabetes
| Article | Year |
|---|---|
[Effects of cilazapril on the expression of vascular endothelial growth factor and intercellular adhesion molecule-1 in diabetic rat glomeruli].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Diabetes Mellitus, Experimental; Glomerular Mesangium; Immunohistochemistry; Intercellular Adhesion Molecule-1; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2003 |
Altered vasoreactivity to angiotensin II in experimental diabetic neuropathy: role of nitric oxide.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Logistic Models; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasomotor System | 1999 |
Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cilazapril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Probability; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Streptozocin | 2001 |